These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7586 related articles for article (PubMed ID: 2606578)

  • 1. Effects of disseminative route on the liver- and lung-colonizing efficiencies of B16 melanoma and colon-26 carcinoma in mice.
    Weiss L; Ward PM
    Int J Cancer; 1989 Dec; 44(6):1104-7. PubMed ID: 2606578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metastatic cascades on metastatic patterns: studies on colon-26 carcinomas in mice.
    Weiss L; Ward PM
    Int J Cancer; 1988 Mar; 41(3):450-5. PubMed ID: 3346111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-to-lung traffic of cancer cells.
    Weiss L; Ward PM; Holmes JC
    Int J Cancer; 1983 Jul; 32(1):79-83. PubMed ID: 6862695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline administration markedly reduces hepatic and pulmonary implantation of B16-F10 melanoma cells in mice.
    Lentini A; Vidal-Vanaclocha F; Facchiano F; Caraglia M; Abbruzzese A; Beninati S
    Melanoma Res; 2000 Oct; 10(5):435-43. PubMed ID: 11095404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapulmonary spread of established B16 melanoma lung metastases and lung colonies.
    Stackpole CW
    Invasion Metastasis; 1990; 10(5):267-80. PubMed ID: 2228515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases.
    Basse P; Herberman RB; Nannmark U; Johansson BR; Hokland M; Wasserman K; Goldfarb RH
    J Exp Med; 1991 Aug; 174(2):479-88. PubMed ID: 1856630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coincident implantation, growth and interaction sites within the liver of cancer and reactive hematopoietic cells.
    Vidal-Vanaclocha F; Alonso-Varona A; Ayala R; Boyano MD; Barberá-Guillem E
    Int J Cancer; 1990 Aug; 46(2):267-71. PubMed ID: 2200755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B16 metastases in mouse liver and lung. II. Morphology.
    Dingemans KP
    Invasion Metastasis; 1988; 8(2):87-102. PubMed ID: 3360594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells.
    Iwai Y; Terawaki S; Honjo T
    Int Immunol; 2005 Feb; 17(2):133-44. PubMed ID: 15611321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect of arsenic trioxide on the pulmonary metastasis of melanoma B16 cells].
    Shi Y; Xia J; Yang TH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Oct; 31(10):1398-400, 1430. PubMed ID: 22097213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-cell traffic in the liver. I. Growth kinetics of cancer cells after portal-vein delivery.
    Barbera-Guillem E; Smith I; Weiss L
    Int J Cancer; 1992 Dec; 52(6):974-7. PubMed ID: 1459739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis.
    Wang HH; McIntosh AR; Hasinoff BB; Rector ES; Ahmed N; Nance DM; Orr FW
    Cancer Res; 2000 Oct; 60(20):5862-9. PubMed ID: 11059784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization.
    Rusciano D; Lorenzoni P; Burger MM
    Oncogene; 1995 Nov; 11(10):1979-87. PubMed ID: 7478516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor and liver drug uptake following hepatic artery and portal vein infusion.
    Sigurdson ER; Ridge JA; Kemeny N; Daly JM
    J Clin Oncol; 1987 Nov; 5(11):1836-40. PubMed ID: 3681370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells.
    Amarzguioui M; Peng Q; Wiiger MT; Vasovic V; Babaie E; Holen T; Nesland JM; Prydz H
    Clin Cancer Res; 2006 Jul; 12(13):4055-61. PubMed ID: 16818705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrodynamic cell delivery for simultaneous establishment of tumor growth in mouse lung, liver and kidney.
    Li J; Yao Q; Liu D
    Cancer Biol Ther; 2011 Oct; 12(8):737-41. PubMed ID: 21832881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs.
    Timmons JJ; Cohessy S; Wong ET
    J Vis Exp; 2016 May; (111):. PubMed ID: 27285567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human granulocyte colony-stimulating factor inhibits the metastasis of hematogenous and non-hematogenous tumors in mice.
    Matsumoto Y; Saiki I; Murata J; Okuyama H; Tamura M; Azuma I
    Int J Cancer; 1991 Sep; 49(3):444-9. PubMed ID: 1717386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new technique for implantation of tissue culture melanoma cells in a murine model of metastatic ocular melanoma.
    Dithmar S; Rusciano D; Grossniklaus HE
    Melanoma Res; 2000 Feb; 10(1):2-8. PubMed ID: 10711634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of Lymphogenous and Hematogenous Metastasizing from Murine В16 Melanoma in Rats.
    Kit OI; Kaplieva IV; Frantsiyants EM; Trepitaki LK
    Bull Exp Biol Med; 2017 Oct; 163(6):793-795. PubMed ID: 29063316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 380.